XML 43 R31.htm IDEA: XBRL DOCUMENT v3.22.4
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]  
Schedule of Option Activity

The following table summarizes option activity during the years ended December 31, 2022 and 2021:

 

   Number of Options   Weighted Average Exercise Price   Weighted Average Fair Value   Weighted Average Remaining Contractual Life (Years) 
Outstanding at December 31, 2020   1,300,588   $2.44   $1.24      
Granted   -    -    -      
Expired   -    -    -      
Forfeited/Cancelled   -    -    -      
Exercised   (189,225)   2.38    1.12      
Outstanding at December 31, 2021   1,111,363   $2.12   $1.31      
Granted   -    -    -      
Expired   -    -    -      
Forfeited/Cancelled   -    -    -      
Exercised   (70,791)   1.10    0.51      
Outstanding at December 31, 2022   1,040,572   $2.19   $1.37    5.88 
                     
Exercisable at December 31, 2022   1,040,572   $2.19   $1.37    5.88 
Schedule of Outstanding Restricted Stock Units and Related Activity

The grant date fair value of RSUs granted is determined using the closing market price of the Company’s common stock on the grant date with the associated compensation expense amortized over the vesting period of the awards. The following table sets forth the outstanding RSUs and related activity for the years ended December 31, 2022 and 2021:

 

   Number of RSUs   Weighted Average Grant Date Fair Value 
Unvested at December 31, 2020   522,500   $10.49 
Granted   1,217,500    9.76 
Vested   (438,502)   10.10 
Forfeited/Cancelled   (34,083)   9.91 
Unvested at December 31, 2021   1,267,415   $9.94 
Granted   1,925,476    5.66 
Vested   (725,166)   8.66 
Forfeited/Cancelled   (41,000)   8.31 
Unvested at December 31, 2022   2,426,725   $7.06 
Schedule of Warrant Activity

The following table summarizes warrant activity during the years ended December 31, 2022 and 2021:

 

   Number of Warrants   Weighted Average Exercise Price   Weighted Average Fair Value   Weighted Average Remaining Contractual Life (Years) 
Outstanding at December 31, 2020   70,000   $1.83   $5.21    3.3 
Granted   456,281    9.13    3.83      
Expired   -    -    -      
Forfeited/Cancelled   -    -    -      
Exercised   -    -    -      
Outstanding at December 31, 2021   526,281   $8.15   $4.01    4.7 
Issued for adjustments to contingent purchase consideration   8,719    9.13    1.88      
Granted   -    -    -      
Expired   -    -    -      
Forfeited/Cancelled   -    -    -      
Exercised   (50,000)   2.00    1.22      
Outstanding at December 31, 2022   485,000   $8.81   $2.43    4.0 
Schedule of Recognized Stock-based Compensation Expense

The Company recognized stock-based compensation expense related to the types of awards discussed above as follows:

 

   2022   2021 
   Years Ended December 31, 
   2022   2021 
Options  $78,115   $292,754 
Restricted stock units   7,465,108    5,164,750 
Stock   -    51,900 
Total stock-based compensation expense  $7,543,223   $5,509,404